Tenon Medical Files 8-K with Financials

TL;DR

Tenon Medical dropped its 8-K on March 13th, check the financials.

AI Summary

On March 13, 2024, Tenon Medical, Inc. filed an 8-K report detailing its financial results and exhibits. The filing includes information related to its common stock and warrants, with a fiscal year end of December 31st. The company is incorporated in Delaware and its principal executive offices are located in Los Gatos, California.

Why It Matters

This filing provides investors with crucial updates on Tenon Medical's financial condition and operational results, impacting investment decisions.

Risk Assessment

Risk Level: low — This is a routine financial filing (8-K) and does not appear to contain any immediately alarming or significant new risks.

Key Numbers

• 1231 — Fiscal Year End (Indicates the end of the company's annual financial reporting period.)

Key Players & Entities

• Tenon Medical, Inc. (company) — Registrant
• March 13, 2024 (date) — Date of earliest event reported
• Delaware (jurisdiction) — State of incorporation
• Los Gatos, CA (location) — Principal executive offices
• TNON (ticker) — Common Stock Ticker

FAQ

Key Financial Figures

• $0.001 — ch registered Common Stock, par value $0.001 per share TNON The Nasdaq Stock Mar

Filing Documents

• ea0201769-8k_tenonmed.htm (8-K) — 31KB
• ea020176901ex99-1_tenonmed.htm (EX-99.1) — 105KB
• 0001213900-24-022411.txt ( ) — 359KB
• tnon-20240313.xsd (EX-101.SCH) — 4KB
• tnon-20240313_def.xml (EX-101.DEF) — 26KB
• tnon-20240313_lab.xml (EX-101.LAB) — 36KB
• tnon-20240313_pre.xml (EX-101.PRE) — 25KB
• ea0201769-8k_tenonmed_htm.xml (XML) — 5KB

02. R esults of Operations and Financial Condition

Item 2.02. R esults of Operations and Financial Condition. On March 12, 2024, Tenon Medical, Inc. (the "Company") issued a press release announcing its earnings for the fourth quarter ended December 31, 2023 and the fiscal year ended December 31, 2023. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information set forth under this Item 2.02, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

01. Financial Statement and Exhibits

Item 9.01. Financial Statement and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release dated as of March 12, 2024. 104 Cover Page Interactive Data File (formatted in Inline XBRL). 1

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: March 13, 2024 TENON MEDICAL, INC. By: /s/ Steven M. Foster Name: Steven M. Foster Title: Chief Executive Officer and President 2

View Full Filing

View this 8-K filing on SEC EDGAR